What is in a name? A decade after changing from VVA to GSM have we come any closer to ending the ‘silent suffering’ of postmenopausal women with genitourinary symptoms?

References

• Sturdee DW, Panay N, International Menopause Society Writing Group. Recommendations for the management of postmenopausal vaginal atrophy. Climacteric. 2010;13(6):509–522. doi: 10.3109/13697137.2010.522875.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Palacios S. Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause. Climacteric. 2014;17(1):3–9. doi: 10.3109/13697137.2013.871696.
   PubMed Web of Science ®Google Scholar
• Bachmann G. Urogenital ageing: an old problem newly recognized. Maturitas. 1995;22(Suppl):S1–S5. doi: 10.1016/0378-5122(95)00956-6.
   PubMedGoogle Scholar
• Parish SJ, Nappi RE, Krychman ML, et al. Impact of vulvovaginal health on postmenopausal women: a review of surveys on symptoms of vulvovaginal atrophy. Int J Womens Health. 2013;5:437–447. doi: 10.2147/IJWH.S44579.
   PubMedGoogle Scholar
• Mili N, Paschou SA, Armeni A, et al. Genitourinary syndrome of menopause: a systematic review on prevalence and treatment. Menopause. 2021;28(6):706–716. doi: 10.1097/GME.0000000000001752.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Martini E, Cucinella L, et al. Addressing Vulvovaginal Atrophy (VVA)/Genitourinary Syndrome of Menopause (GSM) for healthy aging in women. Front Endocrinol (Lausanne). 2019;10:561. doi: 10.3389/fendo.2019.00561.
   PubMed Web of Science ®Google Scholar
• Portman DJ, Gass ML, Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women’s Sexual Health and the North American Menopause Society. Menopause. 2014;21(10):1063–1068. doi: 10.1097/GME.0000000000000329.
   PubMed Web of Science ®Google Scholar
• Panay N. Genitourinary syndrome of the menopause–dawn of a new era? Climacteric. 2015;18(Suppl 1):13–17. doi: 10.3109/13697137.2015.1070564.
   PubMedGoogle Scholar
• Phillips NA, Bachmann GA. The genitourinary syndrome of menopause. Menopause. 2021;28(5):579–588. doi: 10.1097/GME.0000000000001728.
   PubMed Web of Science ®Google Scholar
• Simon JA, Goldstein I, Kim NN, et al. The role of androgens in the treatment of genitourinary syndrome of menopause (GSM): International Society for the Study of Women’s Sexual Health (ISSWSH) expert consensus panel review. Menopause. 2018;25(7):837–847. doi: 10.1097/GME.0000000000001138.
   PubMed Web of Science ®Google Scholar
• Simon JA, Davis SR, Althof SE, et al. Sexual well-being after menopause: an International Menopause Society White Paper. Climacteric. 2018;21(5):415–427. doi: 10.1080/13697137.2018.1482647.
   PubMed Web of Science ®Google Scholar
• Vieira-Baptista P, Marchitelli C, Haefner HK, et al. Deconstructing the genitourinary syndrome of menopause. Int Urogynecol J. 2017;28(5):675–679. doi: 10.1007/s00192-017-3295-6.
   PubMed Web of Science ®Google Scholar
• Streicher LF. Diagnosis, causes, and treatment of dyspareunia in postmenopausal women. Menopause. 2023;30(6):635–649. doi: 10.1097/GME.0000000000002179.
   PubMed Web of Science ®Google Scholar
• Lensen S, Bell RJ, Carpenter JS, et al. A core outcome set for genitourinary symptoms associated with menopause: the COMMA (Core Outcomes in Menopause) global initiative. Menopause. 2021;28(8):859–866. doi: 10.1097/GME.0000000000001788.
   PubMed Web of Science ®Google Scholar
• Cucinella L, Martini E, Tiranini L, et al. Genitourinary syndrome of menopause: should we treat symptoms or signs? Curr Opin Endocr Metab Res. 2022;26:100386. doi: 10.1016/j.coemr.2022.100386.
   Google Scholar
• Phillips C, Hillard T, Salvatore S, et al. Laser treatment for genitourinary syndrome of menopause: Scientific Impact Paper No. 72 (July 2022). BJOG. 2022;129(12):e89–e94. doi: 10.1111/1471-0528.17195.
   PubMed Web of Science ®Google Scholar
• The NAMS 2020 GSM Position Statement Editorial Panel. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause. 2020;27(9):976–992.
   PubMed Web of Science ®Google Scholar
• Faubion SS, Larkin LC, Stuenkel CA, et al. Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women’s Sexual Health. Menopause. 2018;25(6):596–608. doi: 10.1097/GME.0000000000001121.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Cucinella L, Martini E, et al. The role of hormone therapy in urogenital health after menopause. Best Pract Res Clin Endocrinol Metab. 2021;35(6):101595. doi: 10.1016/j.beem.2021.101595.
   PubMed Web of Science ®Google Scholar
• Krychman M, Graham S, Bernick B, et al. The women’s EMPOWER survey: women’s knowledge and awareness of treatment options for vulvar and vaginal atrophy remains inadequate. J Sex Med. 2017;14(3):425–433. doi: 10.1016/j.jsxm.2017.01.011.
   PubMed Web of Science ®Google Scholar
• Vesco KK, Beadle K, Stoneburner A, et al. Clinician knowledge, attitudes, and barriers to management of vulvovaginal atrophy: variations in primary care and gynecology. Menopause. 2019;26(3):265–272. doi: 10.1097/GME.0000000000001198.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Palacios S, Panay N, et al. Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey. Climacteric. 2016;19(2):188–197. doi: 10.3109/13697137.2015.1107039.
   PubMed Web of Science ®Google Scholar
• Panay N, Palacios S, Bruyniks N, et al. Symptom severity and quality of life in the management of vulvovaginal atrophy in postmenopausal women. Maturitas. 2019;124:55–61. doi: 10.1016/j.maturitas.2019.03.013.
   PubMed Web of Science ®Google Scholar